BlackRock’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204K | Hold |
146,550
| – | – | ﹤0.01% | 4596 |
|
|
2025
Q1 | $144K | Buy |
146,550
+4,239
| +3% | +$4.18K | ﹤0.01% | 4623 |
|
|
2024
Q4 | $186K | Sell |
142,311
-1,040
| -0.7% | -$1.36K | ﹤0.01% | 4577 |
|
|
2024
Q3 | $493K | Buy |
143,351
+1,548
| +1% | +$5.33K | ﹤0.01% | 4284 |
|
|
2024
Q2 | $468K | Buy |
141,803
+80,538
| +131% | +$266K | ﹤0.01% | 4309 |
|
|
2024
Q1 | $289K | Sell |
61,265
-1,436
| -2% | -$6.76K | ﹤0.01% | 4453 |
|
|
2023
Q4 | $458K | Sell |
62,701
-269,149
| -81% | -$1.96M | ﹤0.01% | 4371 |
|
|
2023
Q3 | $4.01M | Buy |
331,850
+21,965
| +7% | +$265K | ﹤0.01% | 3681 |
|
|
2023
Q2 | $3.28M | Sell |
309,885
-128,632
| -29% | -$1.36M | ﹤0.01% | 3792 |
|
|
2023
Q1 | $4.32M | Sell |
438,517
-19,599
| -4% | -$193K | ﹤0.01% | 3612 |
|
|
2022
Q4 | $6.74M | Buy |
458,116
+47,640
| +12% | +$701K | ﹤0.01% | 3510 |
|
|
2022
Q3 | $4.98M | Sell |
410,476
-2,591
| -0.6% | -$31.4K | ﹤0.01% | 3683 |
|
|
2022
Q2 | $5.78M | Sell |
413,067
-54,244
| -12% | -$759K | ﹤0.01% | 3678 |
|
|
2022
Q1 | $6.66M | Buy |
467,311
+8,680
| +2% | +$124K | ﹤0.01% | 3719 |
|
|
2021
Q4 | $9.67M | Buy |
458,631
+33,594
| +8% | +$708K | ﹤0.01% | 3626 |
|
|
2021
Q3 | $11.2M | Buy |
425,037
+12,589
| +3% | +$330K | ﹤0.01% | 3574 |
|
|
2021
Q2 | $12.9M | Buy |
412,448
+53,847
| +15% | +$1.68M | ﹤0.01% | 3492 |
|
|
2021
Q1 | $11M | Sell |
358,601
-5,354
| -1% | -$164K | ﹤0.01% | 3451 |
|
|
2020
Q4 | $12.5M | Buy |
+363,955
| New | +$12.5M | ﹤0.01% | 3194 |
|